Concepts (87)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pemphigoid, Bullous | 2 | 2022 | 110 | 1.490 |
Why?
|
Scleroderma, Localized | 1 | 2023 | 79 | 0.870 |
Why?
|
Acitretin | 1 | 2022 | 14 | 0.860 |
Why?
|
Hypereosinophilic Syndrome | 1 | 2022 | 93 | 0.800 |
Why?
|
Turner Syndrome | 1 | 2021 | 130 | 0.740 |
Why?
|
Psoriasis | 1 | 2022 | 901 | 0.470 |
Why?
|
Skin Neoplasms | 5 | 2022 | 5691 | 0.420 |
Why?
|
Lymphoma, T-Cell, Cutaneous | 2 | 2022 | 207 | 0.360 |
Why?
|
Melanoma | 3 | 2022 | 5508 | 0.330 |
Why?
|
Lymphoproliferative Disorders | 2 | 2022 | 524 | 0.330 |
Why?
|
Students, Medical | 3 | 2021 | 1862 | 0.230 |
Why?
|
Skin Diseases | 2 | 2022 | 1066 | 0.230 |
Why?
|
Lymphoma, T-Cell, Peripheral | 1 | 2023 | 134 | 0.200 |
Why?
|
Nevus, Halo | 1 | 2020 | 6 | 0.190 |
Why?
|
Neoplasms | 4 | 2022 | 21675 | 0.190 |
Why?
|
Biological Therapy | 1 | 2022 | 138 | 0.190 |
Why?
|
Myasthenia Gravis | 1 | 2023 | 199 | 0.190 |
Why?
|
Lymphoma, T-Cell | 1 | 2023 | 299 | 0.190 |
Why?
|
Decontamination | 1 | 2021 | 69 | 0.190 |
Why?
|
Social Medicine | 1 | 2021 | 62 | 0.190 |
Why?
|
Myositis | 1 | 2023 | 251 | 0.180 |
Why?
|
Edema | 1 | 2023 | 789 | 0.170 |
Why?
|
Lung Neoplasms | 1 | 2023 | 13112 | 0.170 |
Why?
|
Students, Dental | 1 | 2020 | 159 | 0.160 |
Why?
|
Drug Eruptions | 1 | 2021 | 297 | 0.160 |
Why?
|
Antimalarials | 1 | 2023 | 904 | 0.140 |
Why?
|
Myocarditis | 1 | 2023 | 768 | 0.130 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2023 | 2453 | 0.120 |
Why?
|
Piperidines | 1 | 2022 | 1601 | 0.120 |
Why?
|
Longevity | 1 | 2021 | 1070 | 0.120 |
Why?
|
Humans | 25 | 2023 | 743811 | 0.110 |
Why?
|
Neoplasms, Second Primary | 1 | 2020 | 1063 | 0.110 |
Why?
|
Education, Medical, Undergraduate | 1 | 2021 | 1007 | 0.100 |
Why?
|
Dermatology | 1 | 2022 | 872 | 0.100 |
Why?
|
Curriculum | 2 | 2022 | 3603 | 0.100 |
Why?
|
Pyrimidines | 1 | 2022 | 2945 | 0.090 |
Why?
|
Education, Medical | 1 | 2021 | 1722 | 0.090 |
Why?
|
Retrospective Studies | 9 | 2023 | 77410 | 0.080 |
Why?
|
Skin | 1 | 2022 | 4372 | 0.080 |
Why?
|
Immunosuppressive Agents | 1 | 2021 | 4152 | 0.080 |
Why?
|
Immunotherapy | 1 | 2021 | 4437 | 0.070 |
Why?
|
Case-Control Studies | 1 | 2022 | 21733 | 0.060 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3134 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3241 | 0.050 |
Why?
|
Cross-Sectional Studies | 1 | 2021 | 25032 | 0.050 |
Why?
|
Risk Factors | 3 | 2022 | 72252 | 0.050 |
Why?
|
Skin Pigmentation | 1 | 2022 | 282 | 0.040 |
Why?
|
Hydroxychloroquine | 1 | 2023 | 412 | 0.040 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2022 | 4386 | 0.040 |
Why?
|
Cohort Studies | 1 | 2022 | 40545 | 0.040 |
Why?
|
Disinfection | 1 | 2021 | 191 | 0.040 |
Why?
|
Faculty | 1 | 2022 | 386 | 0.040 |
Why?
|
Upper Extremity | 1 | 2023 | 647 | 0.040 |
Why?
|
Phototherapy | 1 | 2021 | 377 | 0.040 |
Why?
|
Aged | 4 | 2022 | 163178 | 0.040 |
Why?
|
Female | 7 | 2022 | 380020 | 0.030 |
Why?
|
Immunoglobulin M | 1 | 2021 | 1537 | 0.030 |
Why?
|
Schools, Medical | 1 | 2022 | 879 | 0.030 |
Why?
|
Male | 6 | 2022 | 349776 | 0.030 |
Why?
|
Aggression | 1 | 2020 | 752 | 0.030 |
Why?
|
Ligands | 1 | 2022 | 3281 | 0.030 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 738 | 0.030 |
Why?
|
Viral Vaccines | 1 | 2020 | 636 | 0.030 |
Why?
|
Age of Onset | 1 | 2020 | 3268 | 0.030 |
Why?
|
Glucocorticoids | 1 | 2022 | 2107 | 0.030 |
Why?
|
Students | 1 | 2022 | 1647 | 0.030 |
Why?
|
Pandemics | 2 | 2023 | 8385 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2023 | 2984 | 0.020 |
Why?
|
Sexual Behavior | 1 | 2020 | 2049 | 0.020 |
Why?
|
Biopsy | 1 | 2022 | 6750 | 0.020 |
Why?
|
Antibodies, Viral | 1 | 2021 | 3175 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2021 | 4561 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2021 | 3530 | 0.020 |
Why?
|
Middle Aged | 4 | 2022 | 213241 | 0.020 |
Why?
|
Protein Kinase Inhibitors | 1 | 2023 | 5532 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2021 | 57744 | 0.020 |
Why?
|
Delivery of Health Care | 1 | 2022 | 5319 | 0.010 |
Why?
|
Adult | 3 | 2023 | 213889 | 0.010 |
Why?
|
Adolescent | 2 | 2022 | 85729 | 0.010 |
Why?
|
Prognosis | 1 | 2021 | 29052 | 0.010 |
Why?
|
Risk Assessment | 1 | 2021 | 23327 | 0.010 |
Why?
|
Pregnancy | 1 | 2021 | 29140 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2022 | 63042 | 0.010 |
Why?
|
Child | 1 | 2022 | 77637 | 0.010 |
Why?
|
Young Adult | 1 | 2020 | 56392 | 0.010 |
Why?
|
United States | 1 | 2021 | 69859 | 0.010 |
Why?
|
Animals | 1 | 2020 | 168660 | 0.000 |
Why?
|
Concepts
(87)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(53)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_